Sustainable development
Product Carbon Footprint Information Disclosure
Release time:
2026-09-11
Livzon Pharmaceutical integrates climate change response into the management of its entire product value chain, continuously quantifying product carbon performance in accordance with internationally recognized standards, and advancing green manufacturing and product environmental performance improvement.
The Group organized product carbon footprint studies for key active pharmaceutical ingredients (APIs) and completed independent third-party verification. The work was conducted in accordance with ISO 14067:2018, and verification was carried out in accordance with ISO 14064-3:2019 at a reasonable assurance level, generating traceable and verifiable product carbon information.
Key APIs including daptomycin, teicoplanin, vancomycin hydrochloride precipitated powder, and vancomycin hydrochloride lyophilized powder have obtained ISO 14067 product carbon footprint verification statements. The Group will continue to expand its coverage, applying product carbon footprint results to green design, cleaner production, and supply chain collaboration, providing transparent and credible climate information to customers, investors, and all stakeholders.